4//SEC Filing
Jin David 4
Accession 0001104659-22-112522
CIK 0001429260other
Filed
Oct 27, 8:00 PM ET
Accepted
Oct 28, 5:02 PM ET
Size
5.5 KB
Accession
0001104659-22-112522
Insider Transaction Report
Form 4
Jin David
Chief Financial Officer
Transactions
- Award
COMMON STOCK, PAR VALUE $0.001
2022-10-26+1,350,000→ 1,397,829 total
Footnotes (2)
- [F1]Represents an award of 1,350,000 restricted stock units which will vest in 48 equal monthly installments after the grant date, October 26, 2022. The shares underlying the restricted stock units will not be settled until the earlier of the tenth business day of January of the year following certain terminations of service of the Reporting Person from the Issuer and the consummation of a Corporate Transaction (as defined in the Fortress Biotech, Inc. 2013 Stock Incentive Plan); the amount will be distributed in the form of the Issuer's common stock.
- [F2]The total holdings include 1,350,000 shares underlying restricted stock units.
Documents
Issuer
Fortress Biotech, Inc.
CIK 0001429260
Entity typeother
Related Parties
1- filerCIK 0001930732
Filing Metadata
- Form type
- 4
- Filed
- Oct 27, 8:00 PM ET
- Accepted
- Oct 28, 5:02 PM ET
- Size
- 5.5 KB